orforglipron semaglutide A clinical trial for diabetes that pit orforglipron, a diabetes and weight-loss pill developed by Eli Lilly, against oral semaglutide, made by Novo Nordisk, suggests the former pill may have the edge Orforglipron and semaglutide, Comparison

Glucagon-like peptide-1 (GLP-1) receptor agonists, known for their effectiveness in managing diabetes by enhancing insulin secretion, are now under investigation for their potential impact on prostate cancer (PCa)

doi:10.1136/bmj.q1645

What sets it apart from earlier compounds in the same category is its selectivity: it triggers GH release without meaningfully raising cortisol, prolactin, or other hormones that older secretagogues like GHRP-2 and GHRP-6 tended to drag up

It changed how I feel

Protein Protein is the most important nutrient to prioritize on a GLP-1 diet

Below, youll find a simple map of sleep stages, a look at DSIP, and a few options with real human trials